PharmaCyte Biotech, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
ICLRICON plc -0.13%183.782.7%$103.29m
ARGXargenx SE -1.26%353.050.0%$75.94m
VRXValeant Pharmaceuticals International, Inc. -0.72%6.9014.1%$40.60m
BRBRBellRing Brands, Inc. 1.10%20.630.0%$19.75m
RVMDRevolution Medicines, Inc. 0.87%19.720.0%$18.36m
BGXXBright Green Corp. -9.24%1.080.0%$5.91m
USNAUSANA Health Sciences, Inc. -1.41%56.054.2%$3.67m
ANIKAnika Therapeutics, Inc. 1.67%23.809.7%$2.13m
MTPMidatech Pharma Plc -2.68%1.870.0%$0.43m
IBIOiBio, Inc. -5.21%0.170.2%$0.43m
ENVBEnveric Biosciences, Inc. -2.09%4.220.0%$0.38m
FLGCFlora Growth Corp. 3.01%0.710.0%$0.32m
NATRNature's Sunshine Products, Inc. -0.84%8.240.4%$0.32m
BPTSBiophytis SA 0.00%0.630.0%$0.29m
GHSIGuardion Health Sciences, Inc. 0.36%0.140.0%$0.21m

Company Profile

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.